Integer Holdings Corporation

ITGR ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $1.85B $1.72B $1.56B $1.33B $1.22B $1.07B $1.26B $1.22B
Cost of Revenue $1.35B $1.26B $1.15B $985.5M $884.1M $787.7M $903.1M $852.3M
Gross Profit $500.4M $459.0M $409.9M $345.8M $337.0M $285.7M $355.0M $362.7M
Gross Margin 27.0% 26.7% 26.3% 26.0% 27.6% 26.6% 28.2% 29.8%
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $211.7M $185.2M $173.2M $158.1M $141.4M $109.0M $138.7M $142.4M
Operating Income $221.3M $208.2M $163.3M $112.7M $135.7M $120.6M $157.6M $155.6M
Operating Margin 11.9% 12.1% 10.5% 8.5% 11.1% 11.2% 12.5% 12.8%
Interest Expense — — $53.4M $38.6M $31.6M $38.2M $52.5M $99.3M
Pretax Income $125.4M $147.6M $105.4M $68.7M $101.1M $86.2M $105.2M $61.1M
Income Tax Expense $22.6M $26.5M $16.2M $8.9M $8.0M $8.9M $14.0M $14.1M
Net Income $102.8M $119.9M $90.7M $66.4M $96.8M $77.3M $96.3M $168.0M
Net Margin 5.5% 7.0% 5.8% 5.0% 7.9% 7.2% 7.7% 13.8%
EPS (Basic) $2.96 $3.57 $2.72 $2.00 $2.93 $2.35 $2.95 $5.23
EPS (Diluted) $2.89 $3.36 $2.69 $1.99 $2.91 $2.33 $2.92 $5.15
Shares Outstanding (Basic) 34.7M 33.6M 33.3M 33.1M 33.0M 32.8M 32.6M 32.1M
Shares Outstanding (Diluted) 35.6M 35.6M 33.8M 33.4M 33.3M 33.1M 33.0M 32.6M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 2 Older →